Halofuginone induces ERK phosphorylation and synergizes with trametinib in gastric cancer cells
HF exerts its anti-cancer effects in gastric cancer and has a synergistic inhibition with trametinib, which may provide a novel therapeutic strategy for gastric cancer.
Authors
- Xiaofeng Bai (ORCID: https://orcid.org/0000-0003-0195-6779)
- Yuxin Zhong
- Peng Wang
- Liang Tian (ORCID: https://orcid.org/0000-0003-1371-8444)
- Yuemin Sun
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- International Journal of Immunopathology and Pharmacology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1177/03946320251359860
- Citations
- 1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Wu Jieping Medical Foundation